Preparation of fixed antigenic, non-oncogenic and protective neoplastic cells.
作者信息
Hakim A A
出版信息
Experientia. 1977 Apr 15;33(4):518-20. doi: 10.1007/BF01922248.
PMID:862758
Abstract
Transplantable spontaneous mammary adenocarcinoma and sarcoma P 1798 cells were incubated with vibrio cholera neuraminidase (VCN), then fixed cells demonstrated ability to exclude trypan blue dye and to immunized animals and produce cytotoxic sera of high titers. The fixed neuramindase-treated tumor cells became non-oncogenic and protected the host against high doses of fresh untreated homologous tumors.
摘要
相似文献
1
Preparation of fixed antigenic, non-oncogenic and protective neoplastic cells.
Experientia. 1977 Apr 15;33(4):518-20. doi: 10.1007/BF01922248.
2
Tumor therapy of neoplastic diseases with tumor cells and neuraminidase: experimental studies on chessboard vaccination in transplantation tumors.用肿瘤细胞和神经氨酸酶进行肿瘤性疾病的肿瘤治疗：移植瘤棋盘式接种的实验研究
Int J Immunopharmacol. 1987;9(7):841-50. doi: 10.1016/0192-0561(87)90081-6.
3
Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity.
Ann N Y Acad Sci. 1976;276:45-60. doi: 10.1111/j.1749-6632.1976.tb41635.x.
4
Tumor-specific transplantation immunity after cryosurgery.
J Surg Oncol. 1969;1(3):241-6. doi: 10.1002/jso.2930010306.
5
Spontaneous metastasis from primary C3H mouse mammary tumors.原发性C3H小鼠乳腺肿瘤的自发转移。
Cancer Res. 1987 Jan 15;47(2):547-50.
6
Antitumor immune response following injection of neuraminidase-treated sarcoma cells.注射神经氨酸酶处理的肉瘤细胞后的抗肿瘤免疫反应。
Ann Surg. 1975 Mar;181(3):359-62. doi: 10.1097/00000658-197503000-00018.
7
8
Depression of host versus graft immunity and stimulation of tumor growth following partial hepatectomy.
Cancer Res. 1976 May;36(5):1659-63.
9
Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.血清介导的肿瘤细胞免受对其肿瘤特异性抗原具有免疫性的淋巴细胞抑制的保护作用。
Proc Natl Acad Sci U S A. 1969 Feb;62(2):362-8. doi: 10.1073/pnas.62.2.362.
10
[Oncogenic and antigenic characteristics of ATPC/TC cells].
Ann Sclavo. 1975 Mar-Apr;17(2):223-7.
本文引用的文献
1
Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment.霍乱弧菌神经氨酸酶处理增强白血病L1210免疫原性。
Cancer Res. 1971 Dec;31(12):2130-2.
2
Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.使用神经氨酸酶对甲基胆蒽纤维肉瘤进行免疫特异性消退
Surgery. 1971 Jul;70(1):38-46.
3
The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.神经氨酸酶处理的淋巴细胞的血清学行为。同种抗原性和补体敏感性。
Clin Exp Immunol. 1972 Jul;11(3):441-60.
4
Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG.癌症免疫疗法：经神经氨酸酶处理的肿瘤细胞加卡介苗受体中肿瘤的免疫特异性排斥反应
Science. 1971 Nov 5;174(4009):591-3. doi: 10.1126/science.174.4009.591.
5
Human tumor-specific antigens.
Surgery. 1969 Jun;65(6):984-9.
6
7
Immunogenicity of leukemia L1210 cells after neuraminidase treatment.神经氨酸酶处理后白血病L1210细胞的免疫原性。
J Natl Cancer Inst. 1972 Jul;49(1):107-18.
8
Comparative effect of viral and bacterial neuraminidase on the complement sensitivity of lymphoid cells.病毒和细菌神经氨酸酶对淋巴细胞补体敏感性的比较作用
Clin Exp Immunol. 1972 Jan;10(1):139-50.
9
Demonstration of cell-mediated immunity to human neoplasms of various histological types.对各种组织学类型的人类肿瘤的细胞介导免疫的证明。
Int J Cancer. 1971 Jan 15;7(1):1-16. doi: 10.1002/ijc.2910070102.
10
Mechanism of action of BCG vaccine on neoplastic proliferation and host immune responses.卡介苗对肿瘤增殖和宿主免疫反应的作用机制。
J Pharm Sci. 1976 Mar;65(3):339-43. doi: 10.1002/jps.2600650306.
Zotero 插件